Core EM - Emergency Medicine Podcast
Episode 215: Marburg Virus and Global EM
Lessons from Rwanda’s Marburg Virus Outbreak and Building Resilient Systems in Global EM.
Hosts:
Tsion Firew, MD
Brian Gilberti, MD
- The Threat: Marburg Virus Disease is from the same family as Ebola and has historically had a reported fatality rate as high as 90%.
- The Outbreak (Sept. 2024): Rwanda declared an MVD outbreak. The initial cases involved a miner, his pregnant wife (who fell ill and died after having a baby), and the baby (who also died).
- Healthcare Worker Impact: The wife was treated at an epicenter hospital. Eight HCWs were exposed to a nurse who was coding in the ICU; all eight developed symptoms, tested positive within a week, and four of them died.
-
The Turning Point: The outbreak happened in city referral hospitals where advanced medical interventions (dialysis, mechanical ventilation) were available.
- Rapid Therapeutics Access: Within 10 days of identifying Marburg, novel therapies (experimental drugs and monoclonal antibodies) and an experimental vaccine were made available through diplomacy with the US government/CDC and agencies like WHO, Africa CDC, CEPI and more.
- The Outcome: This coordinated effort—combining therapeutics, widespread testing, and years of investment in a resilient healthcare system—helped curb the fatality rate down to 23%.
-
Fragmented Systems: Emergency and surveillance functions often operate in silos, leading to delayed or missed outbreak identification (e.g., inconsistent travel screening at JFK during early COVID-19 vs. African countries).
- Solution: Empowering Emergency Departments and the community as the sentinel site can bridge this gap.
- Limited Frontline Capacity and Protection: Clinicians are often undertrained and underprotected and are frequently not part of the decision-making for surveillance.
-
Weak Governance and Accountability: Unclear command structures and lack of feedback discourage early reporting.
- Enabler: Strong governance and accountability in Rwanda helped contain the virus.
-
Dependence on External Programs: Many low-income countries rely on outside sources for vaccines and therapeutics, slowing response.
- Solution: Invest in local production (e.g., Rwanda’s pre-outbreak investment in developing its own mRNA vaccines).
- Lack of Resource-Smart Innovation: Gaps exist in things like integrating digital triage tools and surveillance systems.
- Start Small and Build Trust: Meaningful work requires humility and relationship over scale or visibility. Focus on local priorities and sustainable change through long-term partnership, not just presence. Avoid the “savior mindset”.
- Be T-Shaped: Be deep in one specialty (e.g., EM) but fluent across other critical areas like policy, finance, and data, as these drive decision-making.
- Focus on Knowledge Transfer: True impact means making yourself less essential over time. Prioritize mentorship, co-creation, and sharing leadership opportunities.
-
Climate and Environmental Crisis: Extreme heat, floods, and vector-borne illnesses will strain emergency systems.
- Preparation: Invest in climate-resilient infrastructure for both EDs and the community.
- Outbreaks and Biosecurity: Future outbreaks will emerge faster than current systems can handle, coupled with challenges from anti-microbial resistance.
-
Conflict, Displacement, and Urbanization: Mass migration and overcrowded cities will require new models of emergency care that are mobile, scalable, and inclusive.
- Preparation: Building resilient healthcare systems ready for crisis mental health and cross-border coordination.
- Digital Tools and AI: These can augment solutions, but investment is needed in data governance and ethical AI that preserves local control and adapts to local capacity.
Read More





Subscribe